Amwell (AMWL) Reports Q4 Revenues Beat; Offers FY21 Revenue Mid-Point Outlook Below Consensus

Go back to Amwell (AMWL) Reports Q4 Revenues Beat; Offers FY21 Revenue Mid-Point Outlook Below Consensus
(NYSE: AMWL) Delayed: 14.19 +0.22 (1.57%)
Previous Close $13.97    52 Week High $ 
Open $13.74    52 Week Low $ 
Day High $14.56    P/E N/A 
Day Low $13.74    EPS $ 
Volume 135,959